WHITEHAWK THERAPEUTICS INC (WHWK) Stock Price, Quote, News and Overview
NASDAQ:WHWK - Nasdaq - US00032Q1040 - Common Stock - Currency: USD
WHWK Quote, Performance and Key Statistics
NASDAQ:WHWK (6/30/2025, 8:00:02 PM)
1.87
-0.06 (-3.11%)
The current stock price of WHWK is 1.87 USD. In the past month the price increased by 10.65%.
WHWK Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.07 | 327.88B | ||
| AMGN | AMGEN INC | 13.45 | 150.13B | ||
| GILD | GILEAD SCIENCES INC | 14.32 | 137.91B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 114.33B | ||
| REGN | REGENERON PHARMACEUTICALS | 11.85 | 56.68B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 42.52B | ||
| ARGX | ARGENX SE - ADR | 95.86 | 33.66B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.18 | 26.19B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.59B | ||
| NTRA | NATERA INC | N/A | 23.07B | ||
| BIIB | BIOGEN INC | 7.94 | 18.40B | ||
| INSM | INSMED INC | N/A | 18.33B |
Related stock screener links
About WHWK
Company Profile
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Morristown, New Jersey and currently employs 40 full-time employees. The company went IPO on 2018-06-26. Its advanced three-asset antibody drug conjugate (ADC) portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. Its assets include HWK-007, HWK-016 and HWK-206. HWK-007 represents a differentiated opportunity to potentially be among the first next-wave ADCs in clinical development for high PTK7-expressing cancers. HWK-016 is the first ADC that targets the membrane-bound portion of MUC16, a glycoprotein often overexpressed in cancers of female origin. HWK-016 is being evaluated in IND-enabling studies. HWK-206 is designed to address the neuronal target, SEZ6, which is often overexpressed in cancers of neuroendocrine origin.
Company Info
WHITEHAWK THERAPEUTICS INC
2 Headquarters Plaza, East Building, 11Th Floor
Morristown NEW JERSEY US
Employees: 40
Phone: 15513212234
WHITEHAWK THERAPEUTICS INC / WHWK FAQ
What is the stock price of WHITEHAWK THERAPEUTICS INC today?
The current stock price of WHWK is 1.87 USD. The price decreased by -3.11% in the last trading session.
What is the ticker symbol for WHITEHAWK THERAPEUTICS INC stock?
The exchange symbol of WHITEHAWK THERAPEUTICS INC is WHWK and it is listed on the Nasdaq exchange.
On which exchange is WHWK stock listed?
WHWK stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for WHITEHAWK THERAPEUTICS INC stock?
8 analysts have analysed WHWK and the average price target is 2.04 USD. This implies a price increase of 9.09% is expected in the next year compared to the current price of 1.87. Check the WHITEHAWK THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is WHITEHAWK THERAPEUTICS INC worth?
WHITEHAWK THERAPEUTICS INC (WHWK) has a market capitalization of 88.10M USD. This makes WHWK a Micro Cap stock.
How many employees does WHITEHAWK THERAPEUTICS INC have?
WHITEHAWK THERAPEUTICS INC (WHWK) currently has 40 employees.
What are the support and resistance levels for WHITEHAWK THERAPEUTICS INC (WHWK) stock?
WHITEHAWK THERAPEUTICS INC (WHWK) has a support level at 1.8 and a resistance level at 2.1. Check the full technical report for a detailed analysis of WHWK support and resistance levels.
Is WHITEHAWK THERAPEUTICS INC (WHWK) expected to grow?
The Revenue of WHITEHAWK THERAPEUTICS INC (WHWK) is expected to grow by 47.36% in the next year. Check the estimates tab for more information on the WHWK EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy WHITEHAWK THERAPEUTICS INC (WHWK) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of WHWK, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of WHWK, evaluating the profitability, health, valuation and growth aspects
- WHITEHAWK THERAPEUTICS INC (WHWK) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- WHITEHAWK THERAPEUTICS INC (WHWK) Sales and EPS estimates to see what analysts future expectations are.
- WHITEHAWK THERAPEUTICS INC (WHWK) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- WHITEHAWK THERAPEUTICS INC (WHWK) Insider and Institutional Ownership to learn about the owners and their transactions.
- WHITEHAWK THERAPEUTICS INC (WHWK) Stock Chart to make your own analysis
- WHITEHAWK THERAPEUTICS INC (WHWK) Latest news and press-releases to stay up to date.
Does WHITEHAWK THERAPEUTICS INC (WHWK) stock pay dividends?
WHWK does not pay a dividend.
When does WHITEHAWK THERAPEUTICS INC (WHWK) report earnings?
WHITEHAWK THERAPEUTICS INC (WHWK) will report earnings on 2025-08-05, before the market open.
What is the Price/Earnings (PE) ratio of WHITEHAWK THERAPEUTICS INC (WHWK)?
WHITEHAWK THERAPEUTICS INC (WHWK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.04).
What is the Short Interest ratio of WHITEHAWK THERAPEUTICS INC (WHWK) stock?
The outstanding short interest for WHITEHAWK THERAPEUTICS INC (WHWK) is 0.47% of its float. Check the ownership tab for more information on the WHWK short interest.
WHWK Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to WHWK.
WHWK Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to WHWK. WHWK has a great financial health rating, but its profitability evaluates not so good.
WHWK Financial Highlights
Over the last trailing twelve months WHWK reported a non-GAAP Earnings per Share(EPS) of -2.04. The EPS increased by 20% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 99.42% | ||
| ROA | 11.8% | ||
| ROE | 12.45% | ||
| Debt/Equity | 0 |
WHWK Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 48% to WHWK. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 92.62% and a revenue growth 47.36% for WHWK